SOX2 and breast cancer: Further supporting the notion that disease-initiating breast CSCs are dependent on AKT signaling, treatment with AKT inhibitors suppresses total cell growth, whereas conventional cytostatics impose a selective advantage on BC cells with active SOX2-regulatory elements.